The Protocol of Choice for Treatment of Snake Bite

Abstract

The aim of the current study is to compare three different methods of treatment of snake bite to determine the most efficient one. To unify the protocol of snake bite treatment in our center, we retrospectively reviewed files of the snake-bitten patients who had been referred to us between 2010 and 2014. They were contacted for follow-up using phone calls. Demographic and on-arrival characteristics, protocol used for treatment (WHO/Haddad/GF), and outcome/complications were evaluated. Patients were entered into one of the protocol groups and compared. Of a total of 63 patients, 56 (89%) were males. Five, 19, and 28 patients were managed by Haddad, WHO, or GF protocols, respectively. Eleven patients had fallen into both GF and WHO protocols and were excluded. Serum sickness was significantly more common when WHO protocol was used while 100% of the compartment syndromes and 71% of deformities had been reported after GF protocol. The most important complications were considered to be deformity, compartment syndrome, and amputation and were more frequent after the use of WHO and GF protocols (23.1% versus 76.9%; none in Haddad; P = NS). Haddad protocol seems to be the best for treatment of snake-bitten patients in our region. However, this cannot be strictly concluded because of the limited sample size and nonsignificant P values.

Vipers of Major clinical relevance in Europe: Taxonomy, venom composition, toxicology and clinical management of human bites

“…This not only hampers a timely intervention and wastes medical and economical resources, but also results in a considerable underestimation of snakebites. While the WHO and other authors have published general protocols to manage snakebites, to date, standardised protocols for Europe are needed to investigate the incidence, morbidity and mortality in relation to viper bites (Mohammad Alizadeh et al, 2016;Nelson et al, 2019;Pizon and Ruha, 2015;Walter et al, 1998;WHO, 2016). This review provides keys to distinguish the main medically relevant European snakes belonging to the genus Vipera (Vipera ammodytes, Vipera aspis, Vipera berus, Vipera latastei, Vipera seoanei and Vipera ursinii, chosen on the basis of their greater diffusion across Europe and the highest number of registered venomous snake bites, according to Paolino et al, (2020)) from other non-dangerous species, the description of venom composition and mode of action of the main toxins and a protocol to support clinicians for the management of Vipera envenomations.…”

Snakebite Advice and Counseling From Artificial Intelligence: An Acute Venomous Snakebite Consultation With ChatGPT

“…The response effectively addresses widespread myths and misconceptions associated with snakebites, helping to reduce misinformation. It offers evidence-based guidance based on current guidelines and practices, ensuring the advice is reliable and accurate [ 7 , 9 , 13 ]. Additionally, the response emphasizes the importance of seeking immediate medical attention and following the guidance of healthcare professionals, which is crucial for the proper evaluation, treatment, and management of snakebites.…”

A Review on the Potential of Antivenom Industry in Bangladesh

“…Snake antivenom is one kind of therapeutic serum that is the only effective treatment choice for snake bite envenoming [24], [25]. Antivenom may be a mono variant or poly variant but the second one is best for treatment cause biting a snake may not be familiar to the victim [26].…”